Database Update: API Import to Russia (June and 1st Half of 2017)
Between January and June 2017, Russia imported 5,600 tons of active pharmaceutical ingredients (API), worth 35.7 bln RUB (free circulation prices). In monetary terms, it is 30% higher than that of the same period of 2016. In physical terms, the dynamics is 7%.
China is the absolute leader in the API import, with 20% of the import in monetary terms, which is, however, 6% lower than that of the same period of 2016. In physical terms though, China imported 69% of all the API import to Russia, with 333 API names. French manufacturers come second, with 16.6% of the import, which is in monetary terms 9% higher than that of the same period of 2016.
Ireland has the biggest growth rates, with the import having risen by nearly 400 times. Pneumococcal monovalent polysaccharide conjugates (antigens for vaccine production for the prevention of pneumococcal infections by Pfizer) account for most of the import. Antigens account for most of the total import volume (5.8%).
Read more about API import to Russia (December 2016 and Yearly Performance) here: http://rncph.com/news/15_02_2017
Tab 1. Top 15 API names with the largest import to Russia (Q1 – Q2 2017), in monetary terms